FeaturedNeurologyPsychology·July 29, 2020·1 min readPimavanserin Reduced Symptoms of Dementia-Related Psychosis in Phase 3 TrialPimavanserin substantially reduces symptoms of psychosis and relapse risk for people living with dementia.Read More